MGTA
Price:
$0.6996
Market Cap:
$42.44M
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that cause acute myeloid leukemia and myelodysplastic syndromes, which is under Phase I/II clinical trial; CD45-antibody drug conjugate that targets HSCs and immune cells, which is in investigational new drug application enabling studies for potential use as a single-agent in autoimmune diseases and hematology-oncology transplants; and MGTA-145 that is in Ph...[Read more]
Industry
Biotechnology
IPO Date
2018-06-21
Stock Exchange
NASDAQ
Ticker
MGTA
According to Magenta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 14.64. This represents a change of 4.51% compared to the average of 14.01 of the last 4 quarters.
The mean historical Current Ratio of Magenta Therapeutics, Inc. over the last ten years is 11.35. The current 14.64 Current Ratio has changed 12.80% with respect to the historical average. Over the past ten years (40 quarters), MGTA's Current Ratio was at its highest in in the June 2018 quarter at 23.13. The Current Ratio was at its lowest in in the March 2017 quarter at 0.
Average
11.35
Median
12.68
Minimum
4.71
Maximum
16.29
Discovering the peaks and valleys of Magenta Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 169.10%
Maximum Annual Current Ratio = 16.29
Minimum Annual Increase = -51.21%
Minimum Annual Current Ratio = 4.71
Year | Current Ratio | Change |
---|---|---|
2022 | 7.95 | -51.21% |
2021 | 16.29 | 22.86% |
2020 | 13.26 | 24.88% |
2019 | 10.62 | -23.89% |
2018 | 13.95 | 10.03% |
2017 | 12.68 | 169.10% |
The current Current Ratio of Magenta Therapeutics, Inc. (MGTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
12.50
5-year avg
12.41
10-year avg
11.35
Magenta Therapeutics, Inc.’s Current Ratio is greater than Assembly Biosciences, Inc. (2.36), greater than Instil Bio, Inc. (12.90), greater than Nuvation Bio Inc. (9.57), greater than Achilles Therapeutics plc (6.04), greater than NextCure, Inc. (9.07), greater than Spero Therapeutics, Inc. (2.68), less than Neoleukin Therapeutics, Inc. (15.33), greater than CytomX Therapeutics, Inc. (1.04),
Company | Current Ratio | Market cap |
---|---|---|
2.36 | $97.57M | |
12.90 | $139.85M | |
9.57 | $885.17M | |
6.04 | $40.69M | |
9.07 | $30.53M | |
2.68 | $59.97M | |
15.33 | $8.20M | |
1.04 | $87.65M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Magenta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Magenta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Magenta Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Magenta Therapeutics, Inc. (MGTA)?
What is the highest Current Ratio for Magenta Therapeutics, Inc. (MGTA)?
What is the 3-year average Current Ratio for Magenta Therapeutics, Inc. (MGTA)?
What is the 5-year average Current Ratio for Magenta Therapeutics, Inc. (MGTA)?
How does the current Current Ratio for Magenta Therapeutics, Inc. (MGTA) compare to its historical average?